
GLP-1 medications are everywhere these days — especially online.
A quick scroll through social media can bring up a wide range of companies and influencers touting the benefits of GLP-1 drugs, and women tend to be the target audience. A recent study in the Journal of Medical Internet Research found most of the posts about GLP-1s highlighted positive benefits for women’s health. And while it’s true that GLP-1 drugs have proven benefits for some people, not all GLP-1 medications are the same. And not everything you’re reading online is true.
Glucagon-like peptide-1 (GLP-1) medications are prescribed to treat and manage Type 2 diabetes and obesity. The medications help control blood sugar, slow digestion and increase fullness, which all help with weight loss.
Commercial GLP-1s (brand names Ozempic, Wegovy, Mounjaro and Zepbound) are regulated by the Food and Drug Administration (FDA) for safety, quality and effectiveness. They undergo rigorous FDA review, clinical testing and manufacturing inspections before being approved for use. But many of the GLP-1s advertised on the internet are compounded GLP-1s, which means the drugs are made in compounding pharmacies, and the products are not approved by the FDA or regulated in the same way as the branded versions.
Compounded GLP-1s serve a limited role when they are used to accommodate specific patient needs, such as an allergy to an ingredient or difficulty swallowing a pill, that cannot be met by an FDA-approved drug. Compounding is also permitted to boost supply during a drug supply shortage. This is what happened when there was a shortage of commercial GLP-1s shortly after they first became available for treating obesity. But the shortage has since ended, and the FDA ordered compounders to stop manufacturing mass-compounded GLP-1 drugs in early 2025.
Although the FDA has declared that the supply shortage is resolved, some companies continue to mass produce compounded versions of GLP-1s, claiming that the drugs are personalized for patient needs by altering the method of delivery (e.g., gummy, injection, spray) or adding unnecessary and unproven ingredients like B12 and glycine. In some cases, products marketed as compounded GLP-1s by bad actors have been found to be counterfeit or to contain ingredients other than what is advertised — meaning they may not even be real GLP-1 drugs at all.
The risks of taking any compounded GLP-1s include:
Compounded GLP-1s can vary in strength, effectiveness and quality, so they should only be taken under the guidance of a healthcare provider (HCP). Staying informed and asking the right questions can help you protect your health and avoid unnecessary risks.
Here’s how to be a smart consumer:
.
Compounded GLP-1s are often promoted as personalized medicine, but they come with risks that should be navigated carefully. Illegitimate companies and counterfeit products are harmful to consumers.
All women deserve safe, effective treatments. Advocating for yourself — and choosing an FDA-approved drug when possible — are key to finding quality medications to treat any health condition.
This educational resource was created with support from Eli Lilly, a HealthyWomen Corporate Advisory Council member.